| Literature DB >> 35578710 |
Mohammad Ali Farzin1, Hassan Abdoos1, Reza Saber2.
Abstract
Currently, the development of biosensors is an urgent need due to the rapid spread of SARS-CoV-2 and the limitations of current standard methods for the diagnosis of COVID-19. Hence, many researchers have focused on the design of high-performance biosensors for measuring coronavirus genes. In this study, a voltammetric genosensor was developed for the determination of SARS-CoV-2 RdRP gene based on the format of cDNA probe/Au@CD core-shell NPs/graphite nanocrystals (GNCs)/paper electrode. For the first time, graphite nanocrystals were used in the electrochemical biosensor design. This genosensor was exposed to different concentrations of virus gene and then the hybridization between cDNA probe and RdRP gene was monitored by redox-active toluidine blue (TB). With increasing the RdRP concentration, the reduction peak current of TB enhanced in a linear range of 0.50 pM-12.00 nM according to the regression equation of I (μA) = 7.60 log CRdRP (pM) + 25.78. The repeatability with a RSD of 2.2% clearly exhibited that the response of modified electrode is stable because of the high adhesion of GNC layer on the paper substrate and the high stability of cDNA-Au@CD bioconjugates. The spike-and-recovery studies showed the acceptable recoveries for the sputum samples (>95%).Entities:
Keywords: Au@CD core–shell NPs; Electrochemical genosensor; Graphite nanocrystals; SARS-CoV-2 RdRP
Year: 2022 PMID: 35578710 PMCID: PMC9093088 DOI: 10.1016/j.microc.2022.107585
Source DB: PubMed Journal: Microchem J ISSN: 0026-265X Impact factor: 5.304
Fig. 1Schematic illustration of electrochemical genosensor format used in this work.
Fig. 2SEM images of (A) pristine paper with magnification of 200x, (B) pristine paper with magnification of 1000x, (C) GNCs deposited on the paper with magnification of 3000x and (D) GNCs deposited on the paper with magnification of 5000x.
Fig. 3Raman spectrum of GNC produced by IBSD; inset of this image shows amorphization trajectory consisting stage 1 from graphite (G) to graphite nanocrystals (GNC) [39], [40].
Fig. 4(A) CV curves and (B) Niquist plots of (a) GNC/paper electrode, (b) Au@CD NPs/GNC/paper electrode, (c) cDNA/Au@CDs NPs/GNC/paper electrode, (d) RdRP/cDNA/Au@CDs NPs/GNC/paper electrode and (e) TB/RdRP/cDNA/Au@CDs NPs/GNC/paper electrode in 0.1 M KCl containing 5 mM Fe(CN)63−/4−.
Fig. 5(A) DPVs of cDNA/Au@CD NPs/GNC/paper electrode into (a) 0 pM, (b) 0.5 pM, (c) 5 pM, (d) 10 pM, (e) 500 pM, (f) 1000 pM, (g) 12000 pM of SARS-CoV-2 RdRP gene and TB (1 mM) in 0.1 M PBS of pH 7.4; (B) Calibration curve of Ip versus log CRdRP; (C) DPVs of cDNA/Au@CDs NPs/GNC/Paper electrode in 1 mM of TB indicator and (a) PBS of pH 7.4, (b) SARS-CoV-2 RdRP gene (10 pM), (c) SARS RdRP gene (100 pM), (d) E gene (100 pM) and (e) a mixture of target (10 pM) and interfering (10-fold) genes.
Spike-and-recovery method for assessing the accuracy of RdRP biosensor.
| Sputum samples | Added gene | RSD (%) | Recovery (%) | |
|---|---|---|---|---|
| 1 | 10.0 pM | 9.7 | 2.2 | 97.0 |
| 2 | 50.0 pM | 48.9 | 1.7 | 97.8 |
| 3 | 500 pM | 490.3 | 1.4 | 98.1 |
Calculated as a mean of four measurements.
Comparison of the analytical performance of different genosensors for SARS-CoV-2 RNA detection.
| Detection method | Format of biosensing strategy | LOD | DLR | Real sample | *Total time | Ref. |
|---|---|---|---|---|---|---|
| EC | CPE–HT18C6(Ag)/CHT/SiQDs@PAMAM/cDNA/RdRP gene | 0.3 pM | 1.0 pM–8.0 nM | Sputum | 35 min | |
| FET | Si/SiO2/RGO/AuNPs/cDNA/RdRP gene | 0.37 fM (PBS) | 10 fM–10 pM | Throat swab, | 64 min | |
| EC | DEP-Chips/GONCs/cDNA/RdRP gene | 186 × 10−9 M | 10−10–10−5 M | ----- | 35 min | |
| ECL | GE/DT/DNA1/DNA2/Ru (bpy)32+ modified DNA3/RdRP gene | 2.67 fM | Up to 100 pM | Serum | 75 min | |
| EC | SPE/Au@Fe3O4-CP-HT/ORF1ab gene/SCX8-RGO-Au-TB-LP-AP | 3 aM | 10− 17–10-12 M | Sputum, Throat swab, Urine, Plasma, Serum, Feces, Oral swab, Whole blood, Saliva | 210 min | |
| EC | SPE/NC (MoS2NSs, GNPs, CHT)/AuNFs/SA/Biotin-crRNA-MB/Cas13a protein/ORF gene or S gene | 4.4 × 10−2 fg mL−1 (ORF gene) | 1 × 10−1–1 × 105 fg mL−1 | Artificial saliva | 90 min | |
| ECL | Electrode/PEI-Ru@Ti3C2@AuNPs/DNA7-Fc/AuNP-DNA1-DNA2-DNA3-DNA4/RdRP gene/DNA5/DNA6/CRISPR-Cas12a | 12.8 aM | Up to 500 aM | Pharyngeal swab | 110 min | |
| ECL | GCE/AuNPs-g-C3N4/DNA1(Y1, Y2 and Y3)/Hairpin1/Hairpin2/DNA-Ru/RdRP gene | 59 aM | Up to 30 fM | Pharyngeal swab | 180 min | |
| ECL | GCE/Nafion/Au@Ti3C2@PEI-Ru(dcbpy)32+/Hairpin DNA/Swing arm/RdRP gene/Nb.BbvCI/DNA-AgNCs | 0.21 fM | 1 fM–100 pM | Serum | 120 min | |
| LSPR | ssDNA-functionalized AuNIs/RdRP gene | 0.22 pM | ----- | ----- | 14 min | |
| NEC | cDNA-AuNPs/N gene | 0.18 ng µL−1 | ----- | Oropharyngeal swab | 10 min | |
| EC | Paper electrode/GNC/Au@CD NPs/cDNA/RdRP gene | 0.15 pM | 0.50 pM-12.00 nM | Sputum | 75 min | This work |
*Total-time was defined as the sample preparation time until the assay time.
EC: Electrochemistry; CPE: Carbon paste electrode; HT18C6(Ag): Silver-incorporated hexathia-18-crown-6; CHT: Chitosan; SiQDs@PAMAM: Poly(amidoamine) coated silicon quantum dots; RdRP: RNA depended RNA polymerase; FET: Field-effect transistor; DEP-Chips: Disposable electrical printed chips; GONCs: Graphene oxide nanocolloids; ECL: Electrochemiluminescence; GE: Gold electrode; CP: Capture probe; HT; Hexane-1-thiol; ORF: open reading frame; SCX8-RGO: p-sulfocalix[8]arene functionalized reduced graphene oxide; TB: Toluidine blue; LP: Label probe; AP: Auxiliary probe; NC: Nonocomposite; MoS2NSs: MoS2 nanosheets; GNPs: Graphene nanoplates; AuNFs: Gold nanoflowes; SA: Streptavidin; crRNA: Complementary reporter RNA; MB: Methylene blue; S gene: Spike gene; PEI: Polyethylenimine; Fc: Ferrocene; CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats; GCE: Glassy carbon electrode; Nb.BbvCI: Nicking endonuclease; DNA-AgNCs: DNA-templated silver nanoclusters; LSPR: Local surface plasmon resonance; AuNIs: Gold nanoislands; N gene: Nucleocaspid gene; NEC: Naked-eye colorimetric GNC: Graphite nanocrystal.